ANPP recalls one batch of Arovan atorvastatin over quality defect
The Agence Nationale des Produits Pharmaceutiques has ordered a batch recall of Arovan atorvastatin 10 mg tablets after identifying a quality defect; the affected…
Read the notice →Home / Alerts & Recalls
Alerts & Recalls
Recalls, falsified medicines, agency alerts and import holds — with batch numbers.
Latest in Alerts & Recalls
Showing 1–8 of 8 notices
ANPP quarantines eight batches of Clamoxyl amoxicillin over quality defect
The Agence Nationale des Produits Pharmaceutiques has imposed a quarantine on eight batches of Clamoxyl 1g amoxicillin tablets after identifying a quality defect.
Read the notice →ANPP recalls one batch of Isotanak ginkgo biloba oral solution over quality defect
The Agence Nationale des Produits Pharmaceutiques has ordered a batch recall of Isotanak ginkgo biloba oral solution after identifying a quality defect; the affected…
Read the notice →ANPP recalls one batch of Ferolam sodium feredetate syrup over quality defect
The Agence Nationale des Produits Pharmaceutiques has ordered a batch recall of Ferolam sodium feredetate syrup after identifying a quality defect; the affected batch…
Read the notice →ANPP recalls one batch of GANT H surgical gloves over quality defect
The Agence Nationale des Produits Pharmaceutiques has ordered a voluntary batch recall and quarantine of GANT H sterile latex surgical gloves, size 6.5, after…
Read the notice →ERIS suspends two batches of Azitromicina Alvyx over physical defects
Cape Verde's Entidade Reguladora Independente da Saúde has suspended marketing and ordered immediate withdrawal of two batches of Azitromicina Alvyx 40 mg/15 ml after…
Read the notice →
Somalia Pharmaceutical Business Council Warns Falsified Brands Could Damage Reputation of Pakistani Medicines
SPBC urges Pakistan's pharmaceutical industry to address alleged brand falsification in Somalia, warning that the conduct of individual traders could undermine confidence in legitimate…
Read the notice →Somaliland suspends sale of YENISOM medicines over missing quality testing
The order covers YENISOM Healthcare's entire range rather than named batches, and the agency says the ground is procedural: required entry testing was not…
Read the notice →Regulatory alerts and news, direct to your inbox
Independent pharmaceutical news and regulatory intelligence covering Africa.